BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11757016)

  • 1. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report.
    de Visscher JG; van der Wal KG; Blanken R; Willemse F
    J Oral Maxillofac Surg; 2002 Jan; 60(1):93-5. PubMed ID: 11757016
    [No Abstract]   [Full Text] [Related]  

  • 2. Giant keratoacanthoma-type low-grade squamous cell carcinoma of the upper lip: Response to intralesional interferon alpha-2B.
    Anadolu R; Akay BN; Bodamyali P; Akyol A
    J Dermatolog Treat; 2011 Aug; 22(4):239-40. PubMed ID: 20666675
    [No Abstract]   [Full Text] [Related]  

  • 3. Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip.
    Spieth K; Gille J; Kaufmann R
    Dermatology; 2000; 200(4):317-9. PubMed ID: 10894963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant intralesional methotrexate before surgical treatment of invasive squamous cell carcinoma of the lower lip.
    Salido-Vallejo R; Garnacho-Saucedo G; Sánchez-Arca M; Moreno-Giménez JC
    Dermatol Surg; 2012 Nov; 38(11):1849-50. PubMed ID: 22861167
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoadjuvant intralesional methotrexate in squamous cell carcinoma of the lip.
    Bergón-Sendín M; Pulido-Pérez A; Suárez-Fernández R
    Australas J Dermatol; 2019 May; 60(2):158-160. PubMed ID: 30357801
    [No Abstract]   [Full Text] [Related]  

  • 6. [Intralesional infusion of methotrexate as neoadjuvant therapy improves the cosmetic and functional results of surgery to treat keratoacanthoma: results of a randomized trial].
    Martorell-Calatayud A; Requena C; Nagore E; Sanmartín O; Serra-Guillén C; Botella-Estrada R; Sanz-Motilva V; Llombart B; Alcañiz-Moscardo A; Guillén-Barona C
    Actas Dermosifiliogr; 2011 Oct; 102(8):605-15. PubMed ID: 21742301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eruptive Keratoacanthomas in a Red Tattoo.
    Linares-Gonzalez L; Ródenas-Herranz T; Galvez-Moreno M; Ruiz-Villaverde R
    Sultan Qaboos Univ Med J; 2020 Aug; 20(3):e372-e373. PubMed ID: 33110656
    [No Abstract]   [Full Text] [Related]  

  • 8. Intralesional methotrexate versus 5-flurouracil in the treatment of keratoacanthoma.
    Nofal A; Alakad R; Wahid R; Hoseiny HAM
    Arch Dermatol Res; 2024 Jun; 316(7):400. PubMed ID: 38878177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A huge verrucous carcinoma of the lower lip treated with intra-arterial infusion of methotrexate.
    Sheen MC; Sheu HM; Lai FJ; Lin SD; Wu CF; Wang YW; Lan CC
    Br J Dermatol; 2004 Sep; 151(3):727-9. PubMed ID: 15377380
    [No Abstract]   [Full Text] [Related]  

  • 10. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective study and review of the literature.
    Annest NM; VanBeek MJ; Arpey CJ; Whitaker DC
    J Am Acad Dermatol; 2007 Jun; 56(6):989-93. PubMed ID: 17504715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional methotrexate as non-surgical therapy for giant keratoacanthoma on the nose.
    Sayan A; Taibjee S; Ilankovan V
    Br J Oral Maxillofac Surg; 2024 Feb; 62(2):203-205. PubMed ID: 38267280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional methotrexate for keratoacanthoma of the nose.
    Cohen PR; Schulze KE; Teller CF; Nelson BR
    Skinmed; 2005; 4(6):393-5. PubMed ID: 16276163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of keratoacanthoma with intralesional methotrexate injections].
    Richard MA; Gachon J; Choux R; Laurans R; Folchetti G; Grob JJ
    Ann Dermatol Venereol; 2000 Dec; 127(12):1097. PubMed ID: 11173689
    [No Abstract]   [Full Text] [Related]  

  • 14. Intralesional methotrexate for keratoacanthomas: A retrospective cohort study.
    Smith C; Srivastava D; Nijhawan RI
    J Am Acad Dermatol; 2020 Sep; 83(3):904-905. PubMed ID: 32268170
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple keratoacanthomas occurring in surgical margins and de novo treated with intralesional methotrexate.
    Veerula VL; Ezra N; Aouthmany M; Graham TA; Wolverton SE; Somani AK
    Cutis; 2016 Dec; 98(6):E12-E15. PubMed ID: 28099546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of keratoacanthomas with intralesional methotrexate.
    Melton JL; Nelson BR; Stough DB; Brown MD; Swanson NA; Johnson TM
    J Am Acad Dermatol; 1991 Dec; 25(6 Pt 1):1017-23. PubMed ID: 1810980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intralesional methotrexate in keratoacanthoma of the nose.
    Hurst LN; Gan BS
    Br J Plast Surg; 1995 Jun; 48(4):243-6. PubMed ID: 7640859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intralesional methotrexate treatment for keratoacanthoma tumors: a retrospective case series.
    Aubut N; Alain J; Claveau J
    J Cutan Med Surg; 2012; 16(3):212-7. PubMed ID: 22713449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual multiple keratoacanthoma in a child successfully treated with 5-fluorouracil.
    Singal A; Mohanty S; Bhattacharya SN; Baruah MC; Singh N
    J Dermatol; 1997 Aug; 24(8):546-8. PubMed ID: 9301151
    [No Abstract]   [Full Text] [Related]  

  • 20. Solitary Large Keratoacanthomas of the Head and Neck: An Observational Study.
    Rossi AM; Park B; Qi B; Lee EH; Busam KJ; Nehal KS
    Dermatol Surg; 2017 Jun; 43(6):810-816. PubMed ID: 28296794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.